2024 |
GSK Plc - ADR
|
Non-Executive Director |
228 K |
- |
2024 |
Intellia Therapeutics Inc
|
Independent Director |
- |
- |
2023 |
Intellia Therapeutics Inc
|
Independent Director |
449.9 K |
-0.0 % |
2023 |
GSK Plc - ADR
|
Non-Executive Director |
- |
- |
2022 |
Intellia Therapeutics Inc
|
Independent Director |
450.0 K |
14.2 % |
2022 |
GSK Plc - ADR
|
Non-Executive Director |
274 K |
13.2 % |
2021 |
Intellia Therapeutics Inc
|
Independent Director |
394.1 K |
40.7 % |
2021 |
GSK Plc - ADR
|
Non-Executive Director |
242 K |
-5.1 % |
2020 |
Intellia Therapeutics Inc
|
Independent Director |
280.2 K |
28.6 % |
2020 |
GSK Plc - ADR
|
Non-Executive Director |
255 K |
-23.0 % |
2019 |
GSK Plc - ADR
|
Non-Executive Director |
331 K |
-15.6 % |
2019 |
Intellia Therapeutics Inc
|
Independent Director |
217.8 K |
-57.8 % |
2018 |
Intellia Therapeutics Inc
|
Independent Director |
515.9 K |
- |
2018 |
GSK Plc - ADR
|
Non-Executive Director |
392 K |
-8.4 % |
2017 |
GSK Plc - ADR
|
Non-Executive Director |
428 K |
-12.3 % |
2016 |
GSK Plc - ADR
|
Non-Executive Director |
488 K |
- |